Healthcare provider profile · identity verified

Byron Kilpatrick, MD

Family Practice · HENDERSON, NV · NPI 1750383360

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	988	457
Amlodipine Besylate	Amlodipine Besylate	746	333
Levothyroxine Sodium	Levothyroxine Sodium	637	295
Lisinopril	Lisinopril	519	244
Losartan Potassium	Losartan Potassium	433	197
Rosuvastatin Calcium	Rosuvastatin Calcium	418	190
Metformin Hcl	Metformin Hcl	414	201
Omeprazole	Omeprazole	365	160
Hydrochlorothiazide	Hydrochlorothiazide	298	132
Metoprolol Succinate	Metoprolol Succinate	246	109
Simvastatin	Simvastatin	240	100
Tamsulosin Hcl	Tamsulosin Hcl	239	106
Metoprolol Tartrate	Metoprolol Tartrate	234	103
Montelukast Sodium	Montelukast Sodium	223	94
Pantoprazole Sodium	Pantoprazole Sodium	195	83
Allopurinol	Allopurinol	193	75
Meloxicam	Meloxicam	192	62
Furosemide	Furosemide	189	81
Alendronate Sodium	Alendronate Sodium	178	78
Gabapentin	Gabapentin	174	82
Albuterol Sulfate Hfa	Albuterol Sulfate	173	60
Potassium Chloride	Potassium Chloride	167	70
Clopidogrel	Clopidogrel Bisulfate	159	66
Famotidine	Famotidine	153	66
Carvedilol	Carvedilol	138	66
Metformin Hcl Er	Metformin Hcl	133	57
Sertraline Hcl	Sertraline Hcl	128	65
Escitalopram Oxalate	Escitalopram Oxalate	115	56
Atenolol	Atenolol	105	44
Fluticasone Propionate	Fluticasone Propionate	98	48
Pravastatin Sodium	Pravastatin Sodium	95	46
Glipizide Er	Glipizide	94	40
Pioglitazone Hcl	Pioglitazone Hcl	92	44
Eliquis	Apixaban	83	38
Ibuprofen	Ibuprofen	83	43
Finasteride	Finasteride	81	32
Trazodone Hcl	Trazodone Hcl	81	49
Glimepiride	Glimepiride	79	29
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	79	35
Jardiance	Empagliflozin	78	30
Citalopram Hbr	Citalopram Hydrobromide	74	30
Duloxetine Hcl	Duloxetine Hcl	71	34
Nifedipine Er	Nifedipine	71	22
Fluoxetine Hcl	Fluoxetine Hcl	70	31
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	70	41
Lovastatin	Lovastatin	69	27
Dropsafe Prep Pads	Alcohol Antiseptic Pads	64	21
Ezetimibe	Ezetimibe	64	31
Glipizide	Glipizide	64	29
Triamcinolone Acetonide	Triamcinolone Acetonide	62	31
Naproxen	Naproxen	61	17
Ozempic	Semaglutide	61	26
Tizanidine Hcl	Tizanidine Hcl	61	25
Hydralazine Hcl	Hydralazine Hcl	57	25
Chlorthalidone	Chlorthalidone	56	21
Acyclovir	Acyclovir	55	26
Baclofen	Baclofen	55	21
Quetiapine Fumarate	Quetiapine Fumarate	51	12
Benazepril Hcl	Benazepril Hcl	49	24
Diclofenac Sodium	Diclofenac Sodium	47	19
Valsartan	Valsartan	47	21
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	45	13
Terazosin Hcl	Terazosin Hcl	45	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	44	16
Celecoxib	Celecoxib	42	18
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	42	19
Clonidine Hcl	Clonidine Hcl	41	20
Doxazosin Mesylate	Doxazosin Mesylate	41	17
Paroxetine Hcl	Paroxetine Hcl	40	13
Fenofibrate	Fenofibrate	37	16
Buspirone Hcl	Buspirone Hcl	36	17
Trulicity	Dulaglutide	34	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	14
Ropinirole Hcl	Ropinirole Hcl	33	15
Donepezil Hcl	Donepezil Hcl	32	13
Irbesartan	Irbesartan	32	14
Januvia	Sitagliptin Phosphate	32	15
Xarelto	Rivaroxaban	32	12
Ibu	Ibuprofen	31	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	31	15
Methocarbamol	Methocarbamol	30	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	29	13
Oxybutynin Chloride	Oxybutynin Chloride	28	14
Synthroid	Levothyroxine Sodium	28	11
Amitriptyline Hcl	Amitriptyline Hcl	27	12
Propranolol Hcl	Propranolol Hcl	26	16
Sumatriptan Succinate	Sumatriptan Succinate	26	suppressed
Topiramate	Topiramate	25	suppressed
Torsemide	Torsemide	24	suppressed
Warfarin Sodium	Warfarin Sodium	24	11
Droplet Pen Needle	Pen Needle, Diabetic	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Lamotrigine	Lamotrigine	22	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	22	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	22	11
Meclizine Hcl	Meclizine Hcl	21	14
Azelastine Hcl	Azelastine Hcl	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	11
Venlafaxine Hcl	Venlafaxine Hcl	20	suppressed
Digoxin	Digoxin	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	19	suppressed
Bupropion Xl	Bupropion Hcl	18	14
Nitroglycerin	Nitroglycerin	18	suppressed
Estradiol	Estradiol	17	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	13
Mounjaro	Tirzepatide	16	suppressed
Primidone	Primidone	16	suppressed
Spironolactone	Spironolactone	16	suppressed
Linzess	Linaclotide	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Breyna	Budesonide/Formoterol Fumarate	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	11
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Olanzapine	Olanzapine	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Telmisartan	Telmisartan	14	suppressed
Verapamil Hcl	Verapamil Hcl	14	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Clonidine	Clonidine	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Calcitriol	Calcitriol	12	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Fenofibrate	Fenofibrate,micronized	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Lurasidone Hcl	Lurasidone Hcl	11	suppressed
Prednisone	Prednisone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error